PAG
Private Advisor Group Portfolio holdings
AUM
$18.6B
1-Year Return
16.36%
This Quarter Return
-3.23%
1 Year Return
+16.36%
3 Year Return
+59.94%
5 Year Return
+99.84%
10 Year Return
+205.75%
AUM
$11.2B
AUM Growth
-$349M
(-3%)
Cap. Flow
+$138M
Cap. Flow
% of AUM
1.24%
Top 10 Holdings %
Top 10 Hldgs %
17.52%
Holding
2,146
New
129
Increased
1,019
Reduced
814
Closed
104
Top Buys
Top Sells
| 1 |
SPDR Portfolio Aggregate Bond ETF
SPAB
|
$18.9M |
| 2 |
SPDR Portfolio Emerging Markets ETF
SPEM
|
$17.9M |
| 3 |
US Treasury 2 Year Note ETF
UTWO
|
$16.2M |
| 4 |
Dimensional US Core Equity 2 ETF
DFAC
|
$12.3M |
| 5 |
Dimensional World ex US Core Equity 2 ETF
DFAX
|
$12.3M |
Sector Composition
| 1 | Technology | 8.58% |
| 2 | Financials | 4.22% |
| 3 | Healthcare | 3.65% |
| 4 | Consumer Discretionary | 3.04% |
| 5 | Industrials | 2.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Citius Pharmaceuticals
CTXR
$20.9M
| $27.4K | ﹤0.01% |
1,600
| – | – |
|
2002
Kopin
KOPN
$345M
| $25.6K | ﹤0.01% |
21,008
-1,125
| -5% | -$1.37K |
|
2003
Globalstar
GSAT
$3.96B
| $25.3K | ﹤0.01% |
+1,286
| New | +$25.3K |
|
2004
United Therapeutics
UTHR
$18.1B
| $24.2K | ﹤0.01% |
+107
| New | +$24.2K |
|
2005
X4 Pharmaceuticals
XFOR
$78.6M
| $23.8K | ﹤0.01% |
727
+67
| +10% | +$2.19K |
|
|
ACB
2006
Aurora Cannabis
ACB
$276M
| $23.6K | ﹤0.01% |
4,030
+185
| +5% | +$1.08K |
|
2007
Opko Health
OPK
$1.07B
| $23.4K | ﹤0.01% |
14,651
-950
| -6% | -$1.52K |
|
|
BFX
2008
DELISTED
BowFlex Inc.
BFX
| $23.2K | ﹤0.01% |
27,250
-2,055
| -7% | -$1.75K |
|
2009
Ginkgo Bioworks
DNA
$660M
| $21.5K | ﹤0.01% |
297
-183
| -38% | -$13.2K |
|
2010
TeraWulf
WULF
$3.58B
| $21.3K | ﹤0.01% |
+16,905
| New | +$21.3K |
|
2011
SoundHound AI
SOUN
$5.81B
| $20.9K | ﹤0.01% |
+10,400
| New | +$20.9K |
|
2012
Innoviz Technologies
INVZ
$317M
| $20.6K | ﹤0.01% |
10,556
+556
| +6% | +$1.08K |
|
2013
iShares MSCI Switzerland ETF
EWL
$1.34B
| $19.8K | ﹤0.01% |
+454
| New | +$19.8K |
|
2014
Hyliion Holdings
HYLN
$309M
| $18.9K | ﹤0.01% |
16,000
| – | – |
|
2015
Akebia Therapeutics
AKBA
$785M
| $18.4K | ﹤0.01% |
+16,141
| New | +$18.4K |
|
2016
ProShares Ultra S&P500
SSO
$7.2B
| $18.1K | ﹤0.01% |
+340
| New | +$18.1K |
|
2017
Clover Health Investments
CLOV
$1.41B
| $18K | ﹤0.01% |
+16,643
| New | +$18K |
|
2018
Playboy, Inc. Common Stock
PLBY
$187M
| $17.8K | ﹤0.01% |
22,247
-631
| -3% | -$505 |
|
2019
American Well
AMWL
$113M
| $15.3K | ﹤0.01% |
654
-81
| -11% | -$1.9K |
|
2020
Bakkt Holdings
BKKT
$122M
| $15.3K | ﹤0.01% |
522
| – | – |
|
2021
Milestone Scientific
MLSS
$48.5M
| $14.1K | ﹤0.01% |
15,300
| – | – |
|
2022
Alaunos Therapeutics
TCRT
$4.27M
| $12.6K | ﹤0.01% |
639
-83
| -11% | -$1.64K |
|
|
AMRN
2023
Amarin Corp
AMRN
$317M
| $12.2K | ﹤0.01% |
+663
| New | +$12.2K |
|
2024
PAVmed
PAVM
$9.77M
| $11.8K | ﹤0.01% |
2,667
-22
| -0.8% | -$97 |
|
|
AEVA
2025
Aeva Technologies
AEVA
$786M
| $11.3K | ﹤0.01% |
2,962
+100
| +3% | +$382 |
|